Pure hyperglyceridemia, more precisely called pure hypertriglyceridemia, is a lipid disorder in which triglyceride levels in the blood are elevated while cholesterol remains normal or near normal. In the Fredrickson classification of lipid disorders, it falls under Type IV hyperlipoproteinemia and affects roughly 1 in 100 people. The condition can be inherited, triggered by lifestyle factors, or both.
How It Differs From Other Lipid Disorders
Most people associate high cholesterol with heart risk, but triglycerides are a separate type of fat in the blood. In pure hypertriglyceridemia, the liver produces too many large particles called VLDL (very low-density lipoproteins), which carry triglycerides through the bloodstream. Unlike mixed lipid disorders where both cholesterol and triglycerides climb together, this condition keeps total cholesterol and LDL cholesterol within normal ranges. That distinction matters because it changes how the condition is monitored and treated.
National guidelines classify triglyceride levels into tiers: borderline high at 150 to 199 mg/dL, high at 200 to 499 mg/dL, and very high above 500 mg/dL. In pure hypertriglyceridemia, levels typically stay below 1,000 mg/dL because the VLDL particles involved carry less triglyceride per particle than the larger chylomicrons seen in more severe genetic lipid disorders.
What Causes Triglycerides to Build Up
The underlying problem is a mismatch between how fast your liver releases triglyceride-rich particles and how fast your body clears them. Normally, an enzyme called lipoprotein lipase breaks down these particles in the bloodstream so tissues can absorb the fat for energy. When production outpaces clearance, triglycerides accumulate. A protein called apolipoprotein C-III plays a key role here: it slows lipoprotein lipase activity, delays particle breakdown, and interferes with the removal of leftover remnants by the liver. People with higher levels of this protein tend to have triglyceride-rich particles that linger in circulation much longer.
As triglycerides rise, abnormalities cascade through the entire chain of lipoprotein processing. Slowly metabolized particles accumulate at multiple stages, and the system becomes increasingly inefficient.
Genetic Causes
Some people inherit mutations that impair triglyceride clearance directly. The most well-studied involve the gene for lipoprotein lipase itself. In people with defective lipoprotein lipase, the clearance rate of large VLDL particles drops by roughly tenfold while production stays normal. Mutations in several other genes produce similar effects by disabling proteins that lipoprotein lipase depends on to function, including its essential activator (apolipoprotein C-II) and proteins that anchor it to blood vessel walls. Familial hypertriglyceridemia tends to run in families and often shows up alongside low HDL (“good”) cholesterol.
Lifestyle and Secondary Causes
Many cases are driven or worsened by modifiable factors. The most common triggers include excess calorie intake, diets high in simple sugars or fat, obesity, physical inactivity, and alcohol. Several medication classes can also push triglycerides up: corticosteroids, oral estrogen, certain blood pressure drugs (beta-blockers and thiazide diuretics), antipsychotic medications, protease inhibitors used in HIV treatment, and immunosuppressants. Poorly controlled diabetes is another major contributor. In practice, most people with pure hypertriglyceridemia have some combination of genetic susceptibility and one or more of these secondary drivers.
Heart Disease Risk
For years, researchers debated whether high triglycerides alone raise heart disease risk or simply travel alongside other risk factors like low HDL. That question is now largely settled. A major meta-analysis of 17 prospective trials found that hypertriglyceridemia is an independent risk factor for cardiovascular disease. For every 88 mg/dL increase in triglycerides, the relative risk of cardiovascular disease rose about 30% in men and 75% in women. Even after adjusting for HDL cholesterol levels, the increased risk remained statistically significant: 14% in men and 37% in women.
Supporting this, clinical trials that lowered triglycerides (without lowering LDL) still reduced coronary events. The greatest benefit in these studies appeared specifically among people who started with elevated triglycerides.
Pancreatitis: The Acute Danger
Beyond long-term heart risk, very high triglycerides pose an immediate threat: acute pancreatitis, a painful and potentially life-threatening inflammation of the pancreas. The risk starts climbing when triglycerides exceed 500 mg/dL and rises sharply above 1,000 mg/dL, where roughly 5% of people will develop an episode. At levels above 2,000 mg/dL, the risk jumps to 10 to 20%. This is the primary reason clinicians treat very high triglycerides urgently rather than taking a wait-and-see approach.
How Pure Hypertriglyceridemia Is Managed
Treatment depends on how high triglycerides are and what’s driving them.
Diet and Lifestyle Changes
Reducing simple sugars and refined carbohydrates is one of the most effective first steps. In meta-analyses of randomized trials, low-carbohydrate diets produced significant triglyceride reductions compared to low-fat diets. Cutting excess calories, increasing physical activity, losing weight, and limiting alcohol all contribute. For people whose triglycerides are mildly or moderately elevated, these changes alone can sometimes bring levels back to normal, especially if a secondary cause like excess alcohol or a high-sugar diet is the main driver.
Medications
When triglycerides are in the high range (200 to 499 mg/dL), statins are often recommended as the initial medication because they address overall cardiovascular risk. Some high-intensity statins can lower triglycerides by up to 43% in people who start with significantly elevated levels.
For severe hypertriglyceridemia above 500 mg/dL, where pancreatitis risk becomes a concern, guidelines call for drugs that target triglycerides more directly. Fibrates work primarily by speeding up the clearance of VLDL from the bloodstream, particularly the largest, most triglyceride-heavy particles. They accomplish this partly by suppressing the production of apolipoprotein C-III, which removes the brake on lipoprotein lipase activity. Prescription omega-3 fatty acid formulations, approved for use at doses of 2 to 4 grams per day, also produce significant triglyceride reductions in this range. These are distinct from over-the-counter fish oil supplements, which contain lower concentrations and are not FDA-approved for treating hypertriglyceridemia.
Symptoms and How It’s Detected
Pure hypertriglyceridemia rarely causes noticeable symptoms until levels are quite high. Some people with chronic elevation develop mild joint pain, particularly in the hands, knees, and ankles. At very high levels, small yellowish fat deposits called xanthomas can appear on the skin. But most people discover the condition through a routine blood test. A standard lipid panel will show elevated triglycerides, and the pattern of normal LDL cholesterol with low HDL cholesterol points toward pure hypertriglyceridemia rather than a mixed lipid disorder.
Because the condition is so often silent, it can go undetected for years. Repeat fasting lipid panels are important for anyone with a family history of high triglycerides, and for those with known secondary risk factors like obesity, diabetes, or heavy alcohol use.